Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the diagnosis and treatment of idiopathic portal hypertension, extrahepatic portal obstruction, and Budd-Chiari syndrome in Japan.
Furuichi Y, Kage M, Ohta M, Ohfuji S, Sasaki H, Hidaka H, Yoshida H, Kanto T, Kusano H, Akahoshi T, Obara K, Hashizume M, Kuniyoshi Y, Kawaguchi T, Okubo H, Ishikawa T, Hirooka M, Iwakiri Y, Nio M, Tanaka A. Furuichi Y, et al. Among authors: kanto t. Hepatol Res. 2024 Nov;54(11):952-969. doi: 10.1111/hepr.14118. Epub 2024 Oct 4. Hepatol Res. 2024. PMID: 39364631
Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma.
Yoshio S, Shimagaki T, Hashida R, Kawaguchi T, Tsutsui Y, Sakamoto Y, Yoshida Y, Kawai H, Yoshikawa S, Yamazoe T, Mori T, Osawa Y, Itoh S, Fukai M, Yoshizumi T, Taketomi A, Mori M, Kanto T. Yoshio S, et al. Among authors: kanto t. Hepatol Res. 2021 Jul;51(7):803-812. doi: 10.1111/hepr.13667. Epub 2021 May 25. Hepatol Res. 2021. PMID: 33998102
Effects of a low-intensity resistance exercise program on serum miR-630, miR-5703, and Fractalkine/CX3CL1 expressions in subjects with No exercise habits: A preliminary study.
Hashida R, Matsuse H, Kawaguchi T, Yoshio S, Bekki M, Iwanaga S, Sugimoto T, Hara K, Koya S, Hirota K, Nakano D, Tsutsumi T, Kanto T, Torimura T, Shiba N. Hashida R, et al. Among authors: kanto t. Hepatol Res. 2021 Jul;51(7):823-833. doi: 10.1111/hepr.13670. Epub 2021 Jun 2. Hepatol Res. 2021. PMID: 34014020
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Hashi K, Doi H, Mori T, Yamazoe T, Yoshio S, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Tamura-Nakano M, Oyama C, Shindou H, Kusano H, Kage M, Ikegami T, Yanaga K, Kanto T. Kawai H, et al. Among authors: kanto t. Hepatology. 2022 Jul;76(1):112-125. doi: 10.1002/hep.32256. Epub 2021 Dec 22. Hepatology. 2022. PMID: 34855990
Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
Kimura M, Nishikawa K, Osawa Y, Imamura J, Yamaji K, Harada K, Yatsuhashi H, Murata K, Miura K, Tanaka A, Kanto T, Kohara M, Kamisawa T, Kimura K. Kimura M, et al. Among authors: kanto t. Hepatol Commun. 2022 Oct;6(10):2732-2747. doi: 10.1002/hep4.2043. Epub 2022 Jul 20. Hepatol Commun. 2022. PMID: 35855613 Free PMC article.
A low-intensity 10-min resistance exercise program that ameliorated hepatic fibrosis indices and altered G-CSF/IP-10/PDGF-BB in a patient with nonalcoholic fatty liver disease: A case report.
Hashida R, Nakano D, Matsuse H, Yoshio S, Tsutsumi T, Kawaguchi M, Koya S, Hirota K, Tajima H, Sumida Y, Kanto T, Kawaguchi T, Hiraoka K. Hashida R, et al. Among authors: kanto t. JGH Open. 2023 Feb 20;7(3):231-234. doi: 10.1002/jgh3.12876. eCollection 2023 Mar. JGH Open. 2023. PMID: 36968574 Free PMC article.
Exercise changes the intrahepatic immune cell profile and inhibits the progression of nonalcoholic steatohepatitis in a mouse model.
Tsutsui Y, Mori T, Yoshio S, Sato M, Sakata T, Yoshida Y, Kawai H, Yoshikawa S, Yamazoe T, Matsuda M, Kakazu E, Osawa Y, Oyama C, Tamura-Nakano M, Kawaguchi T, Yoshizumi T, Kanto T. Tsutsui Y, et al. Among authors: kanto t. Hepatol Commun. 2023 Sep 27;7(10):e0236. doi: 10.1097/HC9.0000000000000236. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37756046 Free PMC article.
250 results